Related Experiment Video
Updated: Aug 10, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Epoetin alfa--focus on dialyzability. Case study of the anemic patient
Abstract:
Epoetin alfa therapy has typically been administered at the end of dialysis. A recently completed in vivo study with a small patient population strengthens previous study findings and suggests that this protein can be safely administered during high-flux dialysis without fear of membrane adsorption. Data indicate that successful use of this technique depends on a variety of factors, including the site of administration. If confirmed, these findings could benefit both patients and clinicians.
Related Concept Videos
Erythropoiesis
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis I: Introduction
Acute Kidney Injury V: Interprofessional Care

